-
Prelim Results of CPTS Disappoints - Analyst Blog
Friday, January 7, 2011 - 5:43pm | 412Conceptus (CPTS) has reported disappointing preliminary results for the fourth quarter and full year of fiscal 2010. The company expects net sales of $36.3-$36.6 million during the fourth quarter which is approximately 1-2% lower than the year-ago quarter, although up 7-8% on a sequential basis...
-
ZOLL & Saints Medical Team Up - Analyst Blog
Friday, January 7, 2011 - 5:33pm | 500Resuscitation devices maker ZOLL Medical (ZOLL) has entered into a multi-faceted collaboration pact with Massachusetts-based community hospital Saints Medical Center. Under the agreement, Saints Medical's emergency medical services (“EMS”) team will collaborate with ZOLL Medical to test new...
-
ZOLL & Saints Medical Team Up - Analyst Blog
Friday, January 7, 2011 - 5:14pm | 500Resuscitation devices maker ZOLL Medical (ZOLL) has entered into a multi-faceted collaboration pact with Massachusetts-based community hospital Saints Medical Center. Under the agreement, Saints Medical's emergency medical services (“EMS”) team will collaborate with ZOLL Medical to test new...
-
Alnylam Sets Product Goals - Analyst Blog
Friday, January 7, 2011 - 11:33am | 678Alnylam Pharmaceuticals (ALNY) recently announced the launch of a new product strategy called “Alnylam 5x15" and also provided guidance and goals for 2011. Alnylam plans to focus its development efforts on ALN-TTR and find a partner for its liver cancer candidate ALN-VSP. Under its “Alnylam...
-
Bearish MACD for Delcath Systems - Tale of the Tape
Friday, January 7, 2011 - 11:03am | 117Delcath Systems, Inc's (DCTH) MACD indicator has entered into bearish territory with a reading of -0.0963. The Zacks #4 Rank (“Sell”) stock decreased slightly to $9.55 in morning trade. The Zacks Consensus Estimate for the year ended 2010 has worsened by a cent over the past two months to a loss of...
-
Alnylam Sets Product Goals - Analyst Blog
Friday, January 7, 2011 - 11:00am | 678Alnylam Pharmaceuticals (ALNY) recently announced the launch of a new product strategy called “Alnylam 5x15" and also provided guidance and goals for 2011. Alnylam plans to focus its development efforts on ALN-TTR and find a partner for its liver cancer candidate ALN-VSP. Under its “Alnylam...
-
Bearish MACD for Delcath Systems - Tale of the Tape
Friday, January 7, 2011 - 10:40am | 117Delcath Systems, Inc's (DCTH) MACD indicator has entered into bearish territory with a reading of -0.0963. The Zacks #4 Rank (“Sell”) stock decreased slightly to $9.55 in morning trade. The Zacks Consensus Estimate for the year ended 2010 has worsened by a cent over the past two months to a loss of...
-
Covidien & Drager Integrate Knowhow - Analyst Blog
Friday, January 7, 2011 - 10:33am | 710Covidien (COV), a leading global health care products company with a focus on mechanical ventilation and respiratory care devices, recently announced the integration of its new Infinity MCable and Nellcor OxiMax knowhow with the Drager Infinity Acute Care System in European nations. The Infinity...
-
Covidien & Drager Integrate Knowhow - Analyst Blog
Friday, January 7, 2011 - 9:45am | 710Covidien (COV), a leading global health care products company with a focus on mechanical ventilation and respiratory care devices, recently announced the integration of its new Infinity MCable and Nellcor OxiMax knowhow with the Drager Infinity Acute Care System in European nations. The Infinity...
-
Deutsche Bank Comments On Medical Device Industry
Friday, January 7, 2011 - 8:21am | 226Biomet's results raise two concerns for Deutsche Bank: incremental US pricing and mix pressure; results suggest the US end of year pick-up may not have been that notable. However, it notes Biomet has proven it is not always a good proxy for what to expect from others. Biomet did acknowledge the...
-
Kensey Nash & Orteq Ink Pact - Analyst Blog
Thursday, January 6, 2011 - 8:03pm | 487Kensey Nash Corporation (KNSY) has entered into a manufacturing agreement with London-based medical devices maker Orteq Sports Medicine. The deal includes a minority equity investment in Orteq by Kensey. Orteq is a global leader in the field of biodegradable polymer technology. The company has...
-
Leadership Shifting from Commodities to Tech 01-06-2011
Thursday, January 6, 2011 - 8:01pm | 796Cusick's Corner The market continues to consolidate, but it's still not exhibiting clear signs of any directional bias. This is not stating that the rally is over, it's a sign that leadership is shifting out of Commodities (thanks to the Dollar move) and more into Tech (XLK). All eyes will be on...
-
Stereotaxis' New Distribution Deal - Analyst Blog
Thursday, January 6, 2011 - 7:30pm | 432Medical equipment maker Stereotaxis Inc. (STXS) has extended its long-standing exclusive global collaboration with its existing strategic partner for the distribution of the approved magnetic ablation catheters through the end of 2015. Under the new agreement, Stereotaxis' distribution...
-
Kensey Nash & Orteq Ink Pact - Analyst Blog
Thursday, January 6, 2011 - 7:17pm | 487Kensey Nash Corporation (KNSY) has entered into a manufacturing agreement with London-based medical devices maker Orteq Sports Medicine. The deal includes a minority equity investment in Orteq by Kensey. Orteq is a global leader in the field of biodegradable polymer technology. The company has...
-
Stereotaxis' New Distribution Deal - Analyst Blog
Thursday, January 6, 2011 - 7:07pm | 432Medical equipment maker Stereotaxis Inc. (STXS) has extended its long-standing exclusive global collaboration with its existing strategic partner for the distribution of the approved magnetic ablation catheters through the end of 2015. Under the new agreement, Stereotaxis' distribution...